You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

FLURBIPROFEN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Flurbiprofen Sodium, and when can generic versions of Flurbiprofen Sodium launch?

Flurbiprofen Sodium is a drug marketed by Bausch And Lomb and is included in one NDA.

The generic ingredient in FLURBIPROFEN SODIUM is flurbiprofen sodium. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flurbiprofen sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Flurbiprofen Sodium

A generic version of FLURBIPROFEN SODIUM was approved as flurbiprofen sodium by BAUSCH AND LOMB on January 4th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FLURBIPROFEN SODIUM?
  • What are the global sales for FLURBIPROFEN SODIUM?
  • What is Average Wholesale Price for FLURBIPROFEN SODIUM?
Summary for FLURBIPROFEN SODIUM
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 4
Raw Ingredient (Bulk) Api Vendors: 30
Clinical Trials: 2
Patent Applications: 94
What excipients (inactive ingredients) are in FLURBIPROFEN SODIUM?FLURBIPROFEN SODIUM excipients list
DailyMed Link:FLURBIPROFEN SODIUM at DailyMed
Drug patent expirations by year for FLURBIPROFEN SODIUM

US Patents and Regulatory Information for FLURBIPROFEN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb FLURBIPROFEN SODIUM flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 074447-001 Jan 4, 1995 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.